DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY

Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY trials appear

Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Completed 1

New hope when CAR-T fails: experimental drug targets stubborn lymphoma

Disease control Completed

This study tested an experimental drug called glofitamab for patients with aggressive lymphomas whose cancer returned or didn't respond after CAR-T cell therapy. The trial enrolled 67 patients across two groups with different lymphoma types. Researchers aimed to see if this new a…

Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY

Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY

Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY trials appear

New hope when CAR-T fails: experimental drug targets stubborn lymphoma